Traumatic Brain Injury (TBI)
The NanoDx™ System for TBI addresses existing diagnostic challenges by providing a quantitative assessment of TBI from a finger stick of blood in a 4 minute test.
The Need
- Existing diagnostic methods include subjective neurological & physical evaluation
- Inaccurate 56% of the time
- Radiation equivalent to up to 200 chest X-rays
- Brain bleed only detected 8% of the time
- Time consuming for both patient and hospital staff
- Expensive capital equipment costs up to $2M
- Increased risk from patients discharged without findings
The NanoDx™️ System for TBI
- Addresses existing diagnostics challenges by providing a quantitative assessment of TBI
- Measurement of GFAP and S100B biomarkers in a blood sample
- Assessment based on a small sample of whole blood in a 4 minute test
- The concentration of biomarkers in the blood is measured, and a quantitative assessment of TBI is provided
- In a preclinical IRB study, 100 patient blood samples were tested and resulted in a 100% sensitivity and 0 false negatives
- Addresses existing diagnostics challenges by providing a quantitative assessment of TBI
- Measurement of GFAP and S100B biomarkers in a blood sample
- Assessment based on a small sample of whole blood in a 4 minute test
- The concentration of biomarkers in the blood is measured, and a quantitative assessment of TBI is provided
- In a preclinical IRB study, 100 patient blood samples were tested and resulted in a 100% sensitivity and 0 false negatives
*The NanoDxTM System has not been evaluated by the FDA or other regulatory agencies.
